4/3/2018

CHINA/DRUGS/FDA/TARIFFS/TRUMP AS PRESIDENT: “The Trump administration’s proposed tariffs on thousands of Chinese-manufactured products would target dozens of key products used by drugmakers, as well as medical devices including pacemakers and artificial joints. The 25 percent tariff would be placed on raw ingredients for drugs such as insulin used by diabetics, the anti-allergic-reaction drug epinephrine, as well as vaccines, blood products and antidepressants, according to the list. The tariffs would also target medical devices and diagnostic equipment including syringes, MRI machines, defibrillators, artificial joints, and pacemakers. More than 80 percent of the ingredients used to make U.S.-consumed drugs are produced outside of the country, according to the Food and Drug Administration. China, along with India, accounts for most of the bulk ingredients and the FDA has called China a ‘major provider.'”

-Robert Langreth and Anna Edney, “Trump Tariffs Target Key Ingredients for Dozens of Drugs,” Bloomberg, April 3, 2018 2:54pm